Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers

Inclusion Criteria: * Scheduled for unilateral cataract surgery (phacoemulsification or extracapsular extraction) with posterior chamber intraocular lens implantation on the day prior to study enrollment * Meet the best corrected visual acuity score requirement * Meet the IOP requirement * Additional inclusion criteria also apply Exclusion Criteria: * Known hypersensitivity or poor tolerance to bromfenac sodium or any component of the study medications or any of the procedural medications * Use of any ocular topical, or systemic medication that could interfere with normal lacrimation, wound healing, the test agent, or the interpretation of study results, within 1 week prior to Day of Surgery * Additional exclusion criteria also apply